Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harbor vs LIV by WellNow

Harbor
Graded #85

Higher grade

vs+9.100000000000001
LIV by WellNow
Graded #264

Lower grade

The verdict

Harbor takes it — 72/100 to 62.9/100.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarbor +23
74
51
Dose & formulationLIV by WellNow +9
64
73
Clinical oversightHarbor +10
89
79
Labs & monitoringHarbor +11
63
52
FulfillmentHarbor +18
81
63
Contract termsLIV by WellNow +8
47
55
Harbor · left barLIV by WellNow · right bar

The numbers

MetricHarborLIV by WellNow
WeighScore72/10062.9/100
GradeCC
Scorecard rank#85#264
Semaglutide$99/mo (starting dose, compounded)$279/mo
Tirzepatide$149/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published5 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Harbor

Graded #85 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
LIV by WellNow

Graded #264 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard